Abstract | AIM: METHODS: A total of 537 patients who had chronic viral hepatitis between January 2011 and December 2014 were included in the study. Serum samples were collected from each patient and tested for anti-HAV using the chemiluminescent microparticle immunoassay. RESULTS: CONCLUSION: At the end of the study, being older than 40 years and living in a rural area were found to be independent risk factors for anti-HAV IgG seropositivity. In conclusion, we recommend that patients younger than 40 years and/or those living in cities and having a chronic liver disease should be vaccinated with the hepatitis A vaccine.
|
Authors | Hale T Özden |
Journal | European journal of gastroenterology & hepatology
(Eur J Gastroenterol Hepatol)
Vol. 28
Issue 3
Pg. 333-7
(Mar 2016)
ISSN: 1473-5687 [Electronic] England |
PMID | 26703930
(Publication Type: Journal Article)
|
Chemical References |
- Hepatitis A Antibodies
- Hepatitis B Surface Antigens
- Hepatitis C Antibodies
- Immunoglobulin G
- RNA, Viral
|
Topics |
- Adolescent
- Adult
- Age Distribution
- Age Factors
- Aged
- Aged, 80 and over
- Coinfection
- Female
- Hepatitis A
(blood, diagnosis, epidemiology)
- Hepatitis A Antibodies
(blood)
- Hepatitis A virus
(immunology)
- Hepatitis B Surface Antigens
(blood)
- Hepatitis B, Chronic
(blood, diagnosis, epidemiology)
- Hepatitis C Antibodies
(blood)
- Hepatitis C, Chronic
(blood, diagnosis, epidemiology)
- Humans
- Immunoglobulin G
(blood)
- Male
- Middle Aged
- RNA, Viral
(blood)
- Risk Factors
- Rural Health
- Seroepidemiologic Studies
- Turkey
(epidemiology)
- Urban Health
- Young Adult
|